Abstract. Positron emission tomography (PET) with fluorine-18-2-d-deoxyglucose (FDG) currently is being integrated into clinical oncology because it provides unique functional information that can be applied to the management of cancer. In particular, it is useful for assessing tumor activity and growth, evaluating efficacy of therapy, and detecting tumor recurrence. Studies have demonstrated the value of whole-body PET-FDG imaging when staging and managing abdominal malignancy.
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Blahd, W., Brown, C., Khonsary, S. et al. PET Scans of Abdominal Malignancy. World J. Surg. 20, 245–247 (1996). https://doi.org/10.1007/s002689900039
Issue Date:
DOI: https://doi.org/10.1007/s002689900039